The Global Resource For Connecting Buyers and Sellers

Frost & Sullivan Publishes Update Coverage Report on DNA Biomedical Solutions Ltd.: Entera’s unsuccessful NASDAQ IPO is not expected to have a significant impact on its clinical plans; Price target affected by a change in the exchange rate.

Equity Research is published in the framework of the Tel Aviv Stock Exchange (TASE) Analysis Program  
TEL AVIV, Israel, Feb. 6, 2018 /PRNewswire/ — The TASE analysis project was launched in 2016 in order to raise investors’ level of knowledge of TASE listed technology and biotec…